Byron Dorgan said...
Dr. Hamburg, but in the second paragraph of your letter last December, you talked about, 'Importing non-FDA-approved drugs represents four potential risks.' No one is talking about importing non-FDA-approved drugs.
Context
Dorgan clarifies that the discussion is about FDA-approved drugs, not non-approved ones.
03/01/2010